Cyprotex (CRX)

 

CRX Share PerformanceMore

52 week high155.00 08/09/16
52 week low63.00 16/10/15
52 week change 82.00 (128.13%)
4 week volume320,724 30/08/16

Latest NewsMore

Form 8.5 (EPT/RI) - Cyprotex Plc

RNS Number: 6709K Nplus1 Singer Capital Markets Ltd 23 September 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt p...

Form 8.5 (EPT/RI) - Cyprotex Plc

RNS Number: 4309K Nplus1 Singer Capital Markets Ltd 21 September 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt p...

Form 8.5 (EPT/RI) - Cyprotex Plc

RNS Number: 3115K Nplus1 Singer Capital Markets Ltd 20 September 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt p...

Form 8.5 (EPT/RI) - Cyprotex Plc

RNS Number: 1871K Nplus1 Singer Capital Markets Ltd 19 September 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt pr...

Form 8.3 - Cyprotex plc

RNS Number: 1133K Charles Stanley & Co. Ltd. 16 September 2016 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: STOCKINVEST LI...

Form 8.5 (EPT/RI) - Cyprotex Plc

RNS Number: 0544K Nplus1 Singer Capital Markets Ltd 16 September 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt p...

Form 8.3 - Cyprotex plc

RNS Number: 9481J Charles Stanley & Co. Ltd. 15 September 2016 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: STOCKINVEST LIM...

Form 8.5 (EPT/RI) - Cyprotex Plc

RNS Number: 9439J Nplus1 Singer Capital Markets Ltd 15 September 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt pr...

Fundamental DataMore

EPS-28.99
Dividend yield0 %

Latest discussion posts More

  • Comments

    Hasn't anyone any comments / views as to what may occur in the future. Or are we just left with a few shareholders now who already know what is happening. INMO.. the ...
    14-Sep-2016
    up protherics
  • Cyprotex Website

    The vacancies under the career section seem to be on the decline.. Hopefully business has not tailed off. I would be interested in any ones view on this
    6-Sep-2016
    up protherics
  • SBS

    Interesting write up on the ADVFN board. SBS ( Source Bioscience has been taken private by Trident. .Personally I hope this does not happen here.. Any premium from this ...
    2-Sep-2016
    up protherics

Users' HoldingsMore

Users who hold Cyprotex also hold..
ROYAL BANK SCOT26%
LLOYDS GRP.23%
CENTRICA19%
VODAFONE GRP.19%
BT GROUP15%

Codes & Symbols

ISINGB00BP25RZ14
SymbolsCRX, LSE:CRX, CRX.L, CRX:LN, LON:CRX, XLON:CRX